• How The New European Health Data Space Will Drive The Development Of AI-Based Tools

    Bio-IT World | The European Health Data Space (EHDS) is an exciting new initiative that aims to advance digital health for all European Union (EU) Member States—the largest European healthcare initiative in history. EHDS has two distinct goals: facilitating the movement of health data across borders for healthcare purposes (EHDS1) and utilizing healthcare data for scientific research and innovation (EHDS2).

    Sep 12, 2025

  • Illumina’s Commercial Launch of Proteomics Assay, Acquisiton of SomaLogic

    Bio-IT World | At the J.P. Morgan Healthcare Conference in January, sequencing company after sequencing company laid out their vision for 2025: the year of the proteome. Illumina joined the chorus. Jacob Thaysen, Illumina’s CEO, highlighted proteomics as a particularly exciting area of focus.

    Sep 10, 2025

  • First-in-Class Dietary Supplement a Potentially Big Win for Babies

    Bio-IT World | Modern medical practices like antibiotics and C-sections, coupled with an industrialized food system that prioritizes high yields and profitability over nutritional quality, have left most babies born today lacking the gut microbes they need before kindergarten to train their immune system for life. The deficiency in these types of Bifidobacterium affects all but a fraction of infants in the United States, putting them at risk for developing atopic disease conditions that include food allergies, eczema, and asthma.

    Sep 9, 2025

  • Microbiome-Based Therapies Hold Promise for Chronic Diseases

    Bio-IT World| Researchers in Denmark report finding a potential new route for developing microbiome-based therapies by providing “a concrete example” of how specific bacterial proteins might be used in the treatment of chronic metabolic diseases. Specifically, they identified a common gut bacterium capable of producing hormone-like proteins measurably influencing weight, bone density, and blood sugar regulation in preclinical models.

    Sep 4, 2025

  • Psilocybin Being Investigated as an Anti-Aging Agent

    Bio-IT World| A large segment of the population holds negative views towards psychedelics, even in therapeutic contexts. Up until a few years ago, those people included Kosuke Kato, Ph.D., assistant professor of medicine at Baylor College of Medicine. His perspective changed when he and Louise Hecker, Ph.D., then working at Emory University, began reading up on the experimental use of psilocybin in treating various psychiatric and age-related neurodegenerative diseases.

    Sep 3, 2025